Detalhe da pesquisa
1.
Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer.
Int J Cancer
; 152(5): 945-951, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35880692
2.
'High proliferative cribriform prostate cancer' defines a patient subgroup with an inferior prognosis.
Histopathology
; 83(6): 853-869, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501635
3.
The relationship between perineural invasion, tumor grade, reactive stroma and prostate cancer-specific mortality: A clinicopathologic study on a population-based cohort.
Prostate
; 76(2): 207-14, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26477789
4.
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature.
Biochim Biophys Acta Rev Cancer
; 1879(2): 189080, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272101
5.
In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis.
Mol Oncol
; 16(15): 2810-2822, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574900
6.
Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneity.
Cancer Gene Ther
; 29(8-9): 1276-1284, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35194199
7.
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
JCI Insight
; 7(4)2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050902
8.
High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity.
Neoplasia
; 23(6): 634-641, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107378